[HTML][HTML] Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
AJ Moss, W Zareba, WJ Hall, H Klein… - … England Journal of …, 2002 - Mass Medical Soc
Background Patients with reduced left ventricular function after myocardial infarction are at
risk for life-threatening ventricular arrhythmias. This randomized trial was designed to …
risk for life-threatening ventricular arrhythmias. This randomized trial was designed to …
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria
…, JA Towbin, A Tsatsopoulou, T Wichter, W Zareba - Circulation, 2010 - Am Heart Assoc
Background— In 1994, an International Task Force proposed criteria for the clinical diagnosis
of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) that facilitated …
of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) that facilitated …
[HTML][HTML] Cardiac-resynchronization therapy for the prevention of heart-failure events
…, SD Solomon, D Wilber, W Zareba - … England Journal of …, 2009 - Mass Medical Soc
Background This trial was designed to determine whether cardiac-resynchronization therapy
(CRT) with biventricular pacing would reduce the risk of death or heart-failure events in …
(CRT) with biventricular pacing would reduce the risk of death or heart-failure events in …
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias
…, P Brink, AAM Wilde, L Toivonen, W Zareba… - Circulation, 2001 - Am Heart Assoc
Background—The congenital long-QT syndrome (LQTS) is caused by mutations on several
genes, all of which encode cardiac ion channels. The progressive understanding of the …
genes, all of which encode cardiac ion channels. The progressive understanding of the …
[HTML][HTML] Reduction in inappropriate therapy and mortality through ICD programming
…, M Shoda, D Wilber, W Zareba - … England Journal of …, 2012 - Mass Medical Soc
Background The implantable cardioverter–defibrillator (ICD) is highly effective in reducing
mortality among patients at risk for fatal arrhythmias, but inappropriate ICD activations are …
mortality among patients at risk for fatal arrhythmias, but inappropriate ICD activations are …
Effectiveness and limitations of β-blocker therapy in congenital long-QT syndrome
AJ Moss, W Zareba, WJ Hall, PJ Schwartz… - Circulation, 2000 - Am Heart Assoc
Background—β-blockers are routinely prescribed in congenital long-QT syndrome (LQTS),
but the effectiveness and limitations of β-blockers in this disorder have not been evaluated. …
but the effectiveness and limitations of β-blockers in this disorder have not been evaluated. …
Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact
JP Daubert, W Zareba, DS Cannom, S McNitt… - Journal of the American …, 2008 - jacc.org
Objectives : This study sought to identify the incidence and outcome related to inappropriate
implantable cardioverter-defibrillator (ICD) shocks, that is, those for nonventricular …
implantable cardioverter-defibrillator (ICD) shocks, that is, those for nonventricular …
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation
however, this characteristic twisting morphology may not be evident in all ECG leads. Second,
episodes of drug-induced TdP usually start with a short-long-short pattern of RR cycles …
episodes of drug-induced TdP usually start with a short-long-short pattern of RR cycles …
Effectiveness of cardiac resynchronization therapy by QRS morphology in the multicenter automatic defibrillator implantation trial–cardiac resynchronization therapy …
W Zareba, H Klein, I Cygankiewicz, WJ Hall, S McNitt… - Circulation, 2011 - Am Heart Assoc
Background— This study aimed to determine whether QRS morphology identifies patients
who benefit from cardiac resynchronization therapy with a defibrillator (CRT-D) and whether it …
who benefit from cardiac resynchronization therapy with a defibrillator (CRT-D) and whether it …
[HTML][HTML] Influence of the genotype on the clinical course of the long-QT syndrome
W Zareba, AJ Moss, PJ Schwartz… - … England Journal of …, 1998 - Mass Medical Soc
Background The congenital long-QT syndrome, caused by mutations in cardiac potassium-channel
genes (KVLQT1 at the LQT1 locus and HERG at the LQT2 locus) and the sodium-…
genes (KVLQT1 at the LQT1 locus and HERG at the LQT2 locus) and the sodium-…